Revolutionize Life Sciences with Agentic AI Solutions
Maxis AI has introduced the first AI Workforce for clinical trials — a supervised execution layer built for regulated clinical environments. Clinical development does not lack visibility; it lacks scalable execution capacity, reliability, and consistent risk mitigation.
3,300+
Clinical trials of experience
Foundation of the platform
27%
Per-patient cost reduction target
By 2027
36%
Operational timeline acceleration
Without compromising governance
Supervised execution at scale
What limits progress is the ability to resolve operational challenges reliably and at scale. Maxis enables sponsors and CROs to execute defined clinical workflows through governed AI agents operating under expert supervision.
This model integrates with existing systems while ensuring controlled access, validation checkpoints, and accountability. Built on experience from more than 3,300 clinical trials, the platform supports operations across study startup, enrollment, data management, statistical programming, medical writing, and risk oversight.
Maxis Core
Supervised AI Workforce
The future we are building toward
Our Vision
Personalized, affordable medicine — a practical reality.
We envision a future where drug development moves closer to everyone, making personalized and affordable medicine a practical reality rather than an expectation.
Our vision beholds the evolution of current manpower-limited scaling to supervised intelligent workforce systems as the foundation of regulated execution.
Human expertise and intelligent systems will operate together to expand execution capacity, compress development timelines, and reduce the cost of innovation — bringing targeted, personalized therapies within practical and economic reach.
Our Mission
Transform clinical development economics through a supervised AI Workforce.
Maxis AI exists to transform clinical development economics by removing execution constraints through a supervised AI Workforce embedded in regulated trial operations.
By 2027, we target up to a 27% reduction in per-patient development cost and a 36% acceleration in operational timelines without compromising governance, quality, or human oversight.
We elevate science by delivering consistent, transparent, and scalable execution across the clinical development lifecycle.
Designed to think.
Built to act.
Orchestrated workflows with human oversight
Maxis combines intelligent workflow orchestration with human oversight, audit traceability, and service-level accountability — increasing throughput without proportional headcount growth.
Capacity aligned with output
By redefining execution capacity, Maxis aligns cost with output, improves portfolio predictability, and maintains regulatory confidence.
A new operating model for clinical development
Our mission is to advance a new operating model for clinical development — helping innovative therapies reach patients faster with discipline, governance, and measurable impact.
Explore our AI Workforce Platform
See how AI agents are transforming study startup, data management, oversight, and regulatory submissions.